GC
ATEX icon

Guggenheim Capital’s Anterix ATEX Stock Holding History

Guggenheim Capital’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,150
Closed -$232K – 1701
2024
Q3 		$232K Sell
6,150
-1,052
-15% -$40.5K ﹤0.01% 1722
2024
Q2 		$285K Buy
+7,202
New +$233K ﹤0.01% 1667

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $530M AUM 69.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Guggenheim Capital's ATEX Position: Q4 2024 in Review

Guggenheim Capital sold out of Anterix (ATEX) in Q4 2024, closing a stake of 6,150 shares — an estimated $232K sold.

Guggenheim Capital first reported a position in ATEX in Q2 2024 and held it in 2 quarters. The position peaked at $285K in Q2 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Guggenheim Capital reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Guggenheim Capital sold 6,150 Anterix shares in Q4 2024, an estimated $232K.
  • Guggenheim Capital first reported a position in Anterix in Q2 2024 and held it in 2 quarters.
  • Guggenheim Capital's Anterix position peaked at $285K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.